LATEST ALERTS
Reynolds American is a subsidiary of British American Tobacco (BAT). US-based Reynolds has been submitting premarket tobacco product applications (PMTA)s to the US Food and Drug Administration (FDA) for its oral nicotine products and non-combustible tobacco products. Follow the company’s progress using the content on these pages, from the latest news briefings to in-depth regulatory and market reports.
Reynolds American has submitted a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) for its Velo nicotine lozenges to remain on the market after September
The Altria Group has filed a lawsuit for patent infringement against RJ Reynolds Vapor Co, a subsidiary of Reynolds American, over its Velo smokeless product
The US tobacco industry is resisting another attempt by the FDA to impose graphic health warnings, claiming in a lawsuit that mandatory warnings would violate their rights under the First Amendment
British American Tobacco (BAT) has a chance to steal a march on its Big Tobacco rivals in the heated-tobacco market after the company became the first to receive approval to sell a heat-not-burn device in the US
BAT has chosen to seek market authorisation in the US for its heat-not-burn product Glo on the basis of its “substantial equivalence” to a previous product, Eclipse – but what are the pitfalls and the advantages in this approach? …
The $49.4bn takeover of Reynolds American by British American Tobacco (BAT) is set to go through next week after being approved by shareholders of both companies.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
